Generation Bio Co. (GBIO)
Feb 9, 2026 - GBIO was delisted (reason: acquired by XOMA)
5.34
-0.40 (-6.97%)
Inactive · Last trade price on Feb 6, 2026
Generation Bio Co. Employees
Generation Bio Co. had 115 employees as of December 31, 2024. The number of employees decreased by 59 or 33.91% compared to the previous year.
Employees
115
Change (1Y)
-59
Growth (1Y)
-33.91%
Revenue / Employee
$132,783
Profits / Employee
-$544,583
Market Cap
36.04M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 115 | -59 | -33.91% |
| Dec 31, 2023 | 174 | 24 | 16.00% |
| Dec 31, 2022 | 150 | 0 | - |
| Dec 31, 2021 | 150 | 50 | 50.00% |
| Dec 31, 2020 | 100 | - | - |
GBIO News
- 10 months ago - XOMA Royalty Enters into Agreement to Acquire Generation Bio - GlobeNewsWire
- 11 months ago - Generation Bio Announces Third Quarter 2025 Financial Results - GlobeNewsWire
- 1 year ago - Generation Bio Announces CEO Transition - GlobeNewsWire
- 1 year ago - Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 1 year ago - Generation Bio Announces 1-for-10 Reverse Stock Split - GlobeNewsWire
- 1 year ago - Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 1 year ago - Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 1 year ago - Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results - GlobeNewsWire